TrialCancer2018

Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).

Nobuyuki Katakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.